15 Biggest Mid-Day Gainers For Tuesday - Cal-Maine Foods (NASDAQ:CALM), Arbutus Biopharma (NASDAQ:ABUS)

Endocyte, Inc. ECYT shares jumped 56.2 percent to $5.67 following 157 percent rally on Monday amid news of global license for PSMA-617. Wedbush upgraded Endocyte from Neutral to Outperform.
Cesca Therapeutics Inc KOOL shares surged 42.2 percent to $5.12 after the company reported an allowance for US Patent application covering a novel method of cell separation.
SG Blocks, Inc. SGBX shares rose 22.1 percent to $5.25 as the company reported securing of 2 low-income housing development projects in NY State.
Vical Incorporated VICL shares gained 21.5 percent to $3.11 after the company reported VL-2397 approval by the FDA for Limited Use Indication.
TDH Holdings Inc PETZ shares rose 19.7 percent to $27.31.
Manhattan Associates, Inc. MANH surged 13.7 percent to $49.11. SunTrust Robinson Humphrey upgraded Manhattan Associates from Hold to Buy.
RMG Networks Holding Corporation RMGN shares climbed 10.8 percent to $2.39. RMG reported the launch of a powerful, next-generation SaaS-based content management platform — Korbyt™.
Myovant Sciences Ltd MYOV shares rose 9.7 percent to $16.10. Myovant Sciences reported successful results from a Takeda study of relugolix.
Conifer Holdings Inc CNFR shares surged 8.4 percent to $6.50. Conifer Holdings reported a reinsurance agreement with Swiss Re to cover loss development up to $17.5 million in excess of June 30 reserves.
CareDx Inc CDNA shares rose 7.8 percent to $4.29. CareDx reported an offering for 3.6 million shares of common stock.
DryShips Inc. DRYS shares gained 7.3 percent to $2.96.
Arbutus Biopharma Corp ABUS shares jumped 7.1 percent to $7.76. Roivant Sciences disclosed a 29.1 percent stake in Arbutus Biopharma.
Westport Fuel Systems Inc (USA) WPRT shares rose 7 percent to $3.38.
Cal-Maine Foods Inc CALM gained 3.4 percent to $43.07. Stephens & Co. upgraded Cal-Maine from Equal-Weight to Overweight.
Paychex, Inc. PAYX rose 3.1 percent to $61.69 after the company reported better-than-expected earnings for its first quarter.

Market News and Data brought to you by Benzinga APIs